BRCA mutated pancreatic cancer: A change is coming
Open Access
- 7 May 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (17), 1943-1958
- https://doi.org/10.3748/wjg.v27.i17.1943
Abstract
Pancreatic cancer remains a leading cause of cancer-related death with few available therapies for advanced disease. Recently, patients with germline BRCA mutations have received increased attention due to advances in the management of BRCA mutated ovarian and breast tumors. Germline BRCA mutations significantly increase risk of developing pancreatic cancer and can be found in up to 8% of patients with sporadic pancreatic cancer. In patients with germline BRCA mutations, platinum-based chemotherapies and poly (ADP-ribose) polymerase inhibitors are effective treatment options which may offer survival benefits. This review will focus on the molecular biology, epidemiology, and management of BRCA-mutated pancreatic cancer. Further more, we will discuss future directions for this area of research and promising active areas of research.Keywords
This publication has 84 references indexed in Scilit:
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerThe New England Journal of Medicine, 2011
- Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and controlEPMA Journal, 2010
- BRCA Germline Mutations in Jewish Patients With Pancreatic AdenocarcinomaJournal of Clinical Oncology, 2009
- Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriersEuropean Journal of Cancer, 2007
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer KindredsCancer Research, 2004
- Cancer Incidence in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 2002
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995